Real World Evaluation of Lunit INSIGHT MMG Technology
Launched by LUNIT INC. · Jan 22, 2024
Trial Information
Current as of March 07, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The study has three main objectives, which will be met through separate sub-studies and analyses.
First, it will investigate and compare the performance of the Lunit INSIGHT MMG tool in combination with a human reader, against the current standard of care (two human readers). Quantitative data will be collected from a prospective, observational cohort study which will take place during routine clinical care at the participating site in parallel to standard care. The main aims will be:
1. To assess and compare the sensitivity and specificity of Lunit INSIGHT MMG combined with a single huma...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Non-Inferiority Study
- • Women 18 years of age or older.
- • Referred to a "one-stop" breast clinic following GP appointment for breast symptoms.
- • Patient and workforce qualitative studies Patients: as above. Workforce: Clinical staff and other key stakeholders involved in the implementation of Lunit INSIGHT MMG both male and female
- • • Able to undergo mammography.
- Exclusion Criteria:
- • Non-Inferiority Study
- • Men will not be included in this study.
- • Women who are not able to tolerate a mammogram or are unable to have one due to physical difficulties in engagement with the technology caused by immobility or being wheelchair bound.
- • Patient and workforce qualitative studies Patients: as above. Workforce: Has no connection to Lunit INSIGHT MMG implementation irrespective of being male or female
Trial Officials
Nisha Sharma
Principal Investigator
The Leeds Teaching Hospital NHS Trust
About Lunit Inc.
Lunit Inc. is a leading healthcare technology company specializing in artificial intelligence for medical imaging and diagnostics. Focused on enhancing cancer detection and treatment, Lunit develops innovative AI-powered solutions that assist healthcare professionals in making more accurate and timely decisions. The company is committed to advancing precision medicine through its cutting-edge research and clinical trials, aiming to improve patient outcomes and streamline workflows in clinical settings. With a strong emphasis on collaboration and scientific rigor, Lunit Inc. is at the forefront of transforming healthcare through technology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leeds, , United Kingdom
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0